Latest Restructuring News

Syrah Resources has opened its retail entitlement offer to raise approximately A$104 million, supported by strategic funding proposals from US and Australian government-linked entities. The capital raise aims to underpin the ramp-up of its Balama graphite mine and Vidalia anode material facility.

Synlait Milk Limited has completed the sale of its North Island assets to Abbott for NZ$307 million, significantly reducing its bank debt and refocusing its operations on Canterbury.

The Star Entertainment Group has completed the first stage of its exit from the Destination Brisbane Consortium, locking in a fixed $18 million annual operator fee and shedding a major debt guarantee.

Korab Resources has progressed the sale of its Geolsec mineral lease ML27362 to Leka Fertiliser Shipping Pty Ltd for $4.35 million plus royalties, navigating buyer restructuring and pending ASX approval.

Nova Minerals has amended its warrant exchange terms, tripling the ratio for Nasdaq-listed warrants to US Holdco warrants as part of its US redomiciliation plan. This adjustment aligns with NYSE listing requirements and signals a strategic step in the company’s transition.

Chariot Resources has locked in a A$3.5 million secured loan facility to refinance existing debt and support its lithium exploration projects, including a major Nigerian acquisition.

Genetic Technologies Limited remains under voluntary administration with minimal cash outflows and $0.276 million in cash as it navigates its Deed of Company Arrangement.

Genetic Technologies Limited remains under voluntary administration while progressing a Deed of Company Arrangement and has completed the sale of its geneType business, ending the quarter with $270,000 in cash.

Xenitra Limited has secured a $30 million AUD sales agreement for Danone products with Rockcheck Group and established its Australian subsidiary as an authorised supplier, marking a major step in its China market strategy.

Genetic Signatures is undertaking a major organisational restructure to cut costs by $5 million and sharpen its commercial focus, aiming to accelerate growth in its diagnostic product offerings.

EML Payments has appointed Adam Olding as its Global CEO, marking a pivotal step in its EML 2.0 transformation and signalling strengthened leadership to drive growth. Concurrently, regulatory developments around its Australian banking licence application introduce new compliance dynamics.

KMD Brands has requested a voluntary suspension of its shares on both the NZX and ASX as it finalises a capital raise, refinancing, and its half-year financial results. The suspension aims to maintain market order while key details remain under negotiation.